The global Medical Nebuliser Market size was valued at USD 1.04 billion in 2021 and is projected to grow at a CAGR of 6.2% during the forecast period from 2022 to 2030.
Medical Nebuliser Market Overview:
Medical Nebuliser facilitates delivery of the drug in mist form to the lungs. Increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis is a major factor driving the demand for nebulizers worldwide. Increasing investments and advancements in drug delivery devices have fueled the growth of the global nebulizer market. Growing geriatric population and increasing incidence of various respiratory diseases are driving the demand for nebulizers. According to the World Health Organization (WHO), about 65 million people worldwide suffer from chronic obstructive pulmonary disease, and about 3 million people die from it each year. Also, in 2019, an estimated 262 million people worldwide had asthma, and 461,000 people died in the same year. Increase in pollution levels, lifestyle changes, increase in smoking, and rapid industrialization are major factors contributing to the growth of respiratory problems. According to the World Health Organization (WHO), about 90% of the population breathes polluted air and about 7 million people die each year from indoor and outdoor pollution. These factors are indirectly fueling the growth of the global nebulizer market.
Medical Nebuliser market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Medical Nebuliser market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.
The global Medical Nebuliser market is the professional and accurate study of various business perspectives such as major key players, key geographies, divers, restraints, opportunities, and challenges. This global research report has been aggregated on the basis of various market segments and sub-segments associated with the global market.
Industry News and Key Developments
- In March 2021, PARI Pharma GmbH received authorization for the LAMIRA nebulizer system to supply ARIKAYCE (amikacin liposome inhalation suspension) in Japan. The system includes a custom medication reservoir that holds an 8.4 mL dose and an aerosol head specifically designed for the aerosolization of ARIKAYCE with a valved aerosol chamber.
- In March 2021, AireHealth collaborated with LucidAct Inc to integrate the LucidAct provider portal with AireHealth's digital health solution to support remote management of chronic obstructive pulmonary disease (COPD) and other chronic respiratory conditions.
Top Key Players included in the Medical Nebuliser Market are
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products, and others.
The Medical Nebuliser market research report is categorized based on type, applications and region.
On the Basis of Type:
- Pneumatic Nebuliser
- Ultrasonic Nebuliser
- Mesh Nebuliser
On the Basis of Application:
- Cystic Fibrosis
- Homecare Settings
- Tabletop Nebulizer
- Portable Nebulizer
On the Basis of Region:
Geographically, the global Medical Nebuliser market has been analyzed in various regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, Europe, and India. The global Medical Nebuliser region is dominating this market in the upcoming future.
Further the regions are divided into countries as follows
- North America
- Rest of North America
- The Netherlands
- Nordic Countries
- Benelux Union
- Rest of Europe
- Rest of Southeast Asia
- South Korea
- Southeast Asia
- Rest of Asia-Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Rest of Latin America
Medical Nebuliser Market report scope
CAGR of 6.2% during the forecast period.
Pneumatic Nebuliser, Ultrasonic Nebuliser, Mesh Nebuliser
COPD, Cystic Fibrosis, Asthma
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products
Regions and Countries Covered
- North America: (US, Canada, Mexico, Rest of North America)
- Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
- The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
- Latin America(Brazil, Argentina, Rest of Latin America)
- Rest Of the World
2017 to 2022
2023 to 2030
The major key questions addressed through this innovative research report:
What are the major challenges in front of the global Medical Nebuliser market?
Who are the key vendors of the global Medical Nebuliser market?
What are the leading key industries of the global Medical Nebuliser market?
Which factors are responsible for driving the global Medical Nebuliser market?
What are the key outcomes of SWOT and Porter’s five analysis?
What are the major key strategies for enhancing global opportunities?
What are the different effective sales patterns?
What will be the global market size in the forecast period?
Any special requirements about this report, please let us know and we can provide custom report.